Clathrate formation in water-cyclic ether systems at high pressures

Experimental data on the investigation of the water-trimethyleneoxide system,P, t, x phase diagram (up to 6 kbar) are presented. The results are compared with those on water systems with ethyleneoxide, 1,3- and 1,4-dioxane, 1,3-dioxolane and tetrahydrofuran, on the basis of which a summarizedP, t, x diagram is plotted for water-cyclic ether systems. It is shown that in all the systems in which a cubic structure II hydrate forms at 1 bar, it eventually turns to cubic structure I under pressure. The nature of high pressure hydrates is discussed.Dedicated to the memory of D. W. Davidson.     

Iodination of alcohols using triphenylphosphine/iodine under solvent-free conditions using microwave irradiation

A straightforward and effective procedure for the conversion of benzylic, allylic and aliphatic alcohols to the corresponding iodides using Ph₃P/I₂ under solvent-free conditions using microwave irradiation is reported.     

Adducts of Rh2[MTPA]4 with some phosphine chalcogenides: nature of binding and ligand exchange

Adducts of four phosphine chalcogenides with the chiral dirhodium complex ([Rh-Rh]) were investigated by variable-temperature 1H and 31P NMR spectroscopy in order to compare their properties as axial ligands. Whereas the selenide (1) and the sulfide (2) are strong ligands with electrostatic attraction and, in addition, a significant orbital (HOMO-LUMO) interaction, the phosphine oxide compounds (P=O) bind primarily via electrostatic attraction and are relatively weak donors. Moreover, the overall bond strength in these adducts depends on steric congestion around the P=O group.     

钼过氧配合物与HSO 在酸性溶液中的反应动力学和机理

用载流法研究了Mo~4O~12(O~2) [简作Mo~4(O~2)~2] 与HSO 在酸性条件(4×10^-3～0.5mol·dm^-3)下的反应动力学,并提出了反应机理.反应经历下列历程:Mo~4(O~2)~2+H~2O Mo~4(O~2)(OOH)(k~1,k~-1) Mo~4(O~2)(OOH)+HSO Mo~4(O~2)OOSO~2+H~2O(k~2,k~-2) Mo~4(O~2)OOSO~2+H~2O Mo~4(O~2)+H~2SO~4(k~1,k~-1)中间产物Mo~4(O~2)再以相同机理继续与HSO 反应.由机理,得到了[S(IV)/k~观察与[H^+],[S(IV)]之间的线性关系式以及20℃时的动力学参数:K~1=7.4±0.3dm^3·mol^-1·S^-1,k~-1/k~2=(5.8±0.5)×10^-2和k~-2/k~3=(1.4×0.8)×10^-4.配合物Mo~4(O~2)~2中(O~2)基质子化是决定反应速度的关键步骤.用此机理讨论了Thompson研究的 MoO(O~2)~2与HSO 的反应结果.     

分子内环加成的甾体全合成

近年来,分子内环加成反应已广泛用于甾体化合物全合成,其主要一步是由取代的苯并环丁烯热裂而成的5,6-二亚甲基-1,3-环己二烯发生区域专一和立体选择性的环加成反应,构成甾体骨架。现在用此法已合成了一系列消旋和光学活性的甾体化合物。     

三碘化钐促进的α, α'-二(取代亚苄基)环戊酮的简便合成

在SmI3作用下和中性室温的条件下, 环戊酮能与醛缩合, 得到几乎定量产率的α, α'-二亚苄基环戊酮; 但对环己酮, 产率仅在20%左右。     

Synthesis and characterization of surface-cyanofunctionalized poly (N-isopropylacrylamide) latexes

 A series of P[N-isopropylacrylamide (NIPAM)] latexes with different contents of cyano groups were successfully prepared by either seeded or shot-growth polymerizations of an aqueous solution containing acrylonitrile (AN) onto a seed P[NIPAM] latex, respectively, and further characterized by FT-IR, ¹H-NMR, elemental analysis, as well as by quasielastic light scattering (QELS) and scanning electron microscopy (SEM). All prepared surface-cyanofunctionalized P[NIPAM] latexes exhibited the same range of lower critical solution temperature (LCST) as a pure P[NIPAM] latex. The shot polymerization process proved more efficient at yielding cyano derivatized latexes than the seeded polymerization technique. The amount of incorporated cyano groups onto the particles was determined with a good correlation both by ¹H-NMR and elemental analysis. The higher the amount of initially introduced AN monomer in the reaction mixture, the more cyano groups were incorporated onto the particles. The surface of the particles with high content of cyano groups appeared quite rough by SEM in comparison with that of the pure P[NIPAM] particles. Received: 25 February 1998 Accepted: 23 June 1998     

Circularly Polarized Absorption Property of Tetra-4[4''''-(2-methylbutoxy)benzoyloxy]phenyl Porphyrin by Introducing Optical Pendant Groups

Circularly polarized luminescent(CPL) materials possess special dissymmetric optical property, i.e. luminescent light having different intensities for left (L) and right(R) circularly polarized components. Recently, these materials have been applied in colour-image projection, stereoscopic displays and light-emitting diodes(LEDS)1-7. We have synthesized a new porphyrin derivative, tetra-4[4'-(2-methylbutoxy)benzoyloxy] phenyl porphyrin [T(MBBP)P], by introducing a chiral group, which p…     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.